In an unusual move, Lilly seeks pitches from US states for slice of $27B buildout
Eli Lilly is doing something out of the box to find where it should pour its latest manufacturing commitment.
In a company first, the pharma …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
